Wire · opportunities
Clinical trial to evaluate blood test for early detection of breast cancer
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 15 October 2026 · Fusion42 review
USC Norris Comprehensive Cancer Center has launched a clinical trial to evaluate a blood test designed to detect breast cancer earlier than mammograms by identifying rare cancer cells and tumor-associated particles in the blood. The trial aims to improve early detection, especially for women who face barriers to mammography.
This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 15 Oct 2026 and 17 Oct 2026.
◆ ◆ The Wire takeaway
You should prepare for new diagnostic tools that could change breast cancer screening by reducing reliance on mammograms alone. If validated, this blood test opens access to screening for remote or underserved patients, expanding your market opportunity.
◆ Coverage
2 sources · first reported 15 Oct 2026 · latest 17 Oct 2026
◆ Related on Wire
◆ Topics